Viatris Pharmaceutical Product

Viatris is a global healthcare company formed in 2020 through the combination of Mylan and Upjohn, a legacy division of Pfizer. As a specialist in both generic and branded medicines, Viatris operates a vast global manufacturing network, producing pharmaceuticals in various locations including India, Europe, and North America. The brand reflects a significant shift in the pharmaceutical landscape, bringing together diverse portfolios to provide a wide range of therapeutic products. Its manufacturing is highly decentralized to serve global markets efficiently, often utilizing facilities acquired through its founding companies.